Adoption of Prescription DTx: Best Practices & Challenges

A company might be able to create excellent digital therapeutics (DTx), but it won't have much of an impact if no one uses them. Adoption, or more specifically getting patients and doctors to start using and engage with DTx products, is one of the biggest challenges for prescription DTx (PDT). In this meeting, we will look at how we can approach the problem and how some have already solved it.